Erste Asset Management’s Inhibrx INBX Stock Holding History

Erste Asset Management’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,175	Closed	-$33.8K	–	553
2024 Q3	$33.8K	Hold	2,175	–	–	﹤0.01%	517
2024 Q2	$30.6K	Buy	+2,175	New	+$34K	﹤0.01%	517

Other funds holding INBX

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Slotnik Capital Dallas, Texas $342M AUM 105.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Erste Asset Management's INBX Position: Q4 2024 in Review

Erste Asset Management sold out of Inhibrx (INBX) in Q4 2024, closing a stake of 2,175 shares — an estimated $33.8K sold.

Erste Asset Management first reported a position in INBX in Q2 2024 and held it in 2 quarters. The position peaked at $33.8K in Q3 2024. 101 funds tracked by Wall St. Rank hold INBX as of Q4 2024.

Erste Asset Management reported no remaining Inhibrx position as of Q4 2024 after selling out during the quarter.
Erste Asset Management sold 2,175 Inhibrx shares in Q4 2024, an estimated $33.8K.
Erste Asset Management first reported a position in Inhibrx in Q2 2024 and held it in 2 quarters.
Erste Asset Management's Inhibrx position peaked at $33.8K in Q3 2024.
101 funds tracked by Wall St. Rank held Inhibrx as of Q4 2024.

Based on Erste Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.